AventaMed DAC news
AventaMed are delighted to partner with PROSA for the 1st European Conference on Pediatric Procedural Sedation and Analgesia in Maastricht, The Netherlands, November 29th & 30th 2018.
Come say hello to us at booth 7 and learn more about the Solo TTD. For more information or to schedule a meeting, contact ciara.omahony@aventamed.com
PSA represents a relatively new field in modern medicine, involving a heterogeneous group of medical professions. During this conference you wi
AventaMed will exhibit at the 2019 American Academy of Otolaryngologists (AAO) Annual Meeting & OTO Experience, September 15th – 18th in New Orleans, LA. Come say hello to us at booth 432 in the Emerging Technologies Pavillion and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com
In its 123rd year, the AAO-HNSF Annual Meeting & OTO Experience will feature all day cutting-edge education programming, and dynami
AventaMed will exhibit at the 20th International Symposium on Recent Advances in Otitis Media at the Loews Hollywood in Los Angeles, CA on June 9 – 13, 2019.
Come say hello to us at booth 5 and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com
The International Society for Otitis Media is a non-profit organization that provides an international forum to adv
AventaMed will exhibit at the 2018 American Academy of Otolaryngologists (AAO) Annual Meeting & OTO Experience, October 7 – 10th in Atlanta, Georgia. Come say hello to us at booth 3326 and learn more about the Solo TTD. For more information or to schedule a meeting, contact john.vaughan@aventamed.com
In its 122nd year, the AAO-HNSF Annual Meeting & OTO Experience will feature all day cutting-edge education programming, and dynamic evening events drawing more than 5,500 o
AventaMed, a Cork-based medical device start-up which is set to revolutionise paediatric ear, nose and throat surgery has beaten 26 global organizations in a major medical device bid.
The pioneering company will be one of 12 Real-World Evidence Test-Cases selected by The National Evaluation System for Health Technology Coordinating Center (NESTcc) to evaluate the use of real-world evidence (RWE) in medical device regulatory processes.
AventaMed is the first and only Irish comp